Skip to main content
11 November 2026
08 May 2026

TORL BioTherapeutics Strengthens Leadership with CEO Appointment of Aran Maree

TORL BioTherapeutics LLC (TORL), a clinical stage oncology focused biotechnology company, announced a leadership transition to position the Company for its next phase of growth. Effective as of May 1, 2026, Aran Maree, M.D., is appointed Chief Executive Officer (CEO) and Board Member. Dr. Maree succeeds Mark Alles, wh…

07 May 2026

Capsa Healthcare Names Jeff Schlossnagle Chief Executive Officer

Capsa Healthcare, a global healthcare technology leader, announced the appointment of Jeff Schlossnagle as Chief Executive Officer. Schlossnagle succeeds Gaurav Agarwal and assumes the role to optimize a continued path of significant growth within the areas of clinical workflow, supply chain management, and central fi…

05 May 2026

Viatris Announces Chief Financial Officer Transition

Viatris Inc. , a global healthcare company, announced that Theodora "Doretta" Mistras, Chief Financial Officer, will depart the Company for a new professional opportunity. Viatris has named Paul Campbell, currently Chief Accounting Officer and Corporate Controller, as interim Chief Financial Officer, effective May 8,…

29 April 2026

Echosens Appoints Romain Baujard as Group Chief Executive Office

Echosens, a global diagnostic company specializing in non-invasive medical devices and services, announced the appointment of Romain Baujard as Group Chief Executive Officer, effective May 1, 2026.  "I am honored to take on this responsibility," said Baujard. "Echosens is at a key turning point as innovation accelera…

24 April 2026

Avantor Appoints Ludovic Brellier as EVP & Chief Transformation Officer

Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Ludovic Brellier will join the company as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer on May 1…

22 April 2026

BioMarin Announces Board Leadership Transition

BioMarin Pharmaceutical Inc. said that the Board of Directors has appointed Ian T. Clark as Chair of the Board, subject to his election at the company's Annual Meeting of Stockholders on June 2, 2026. Mr. Clark will succeed Richard A. Meier, who is retiring after two decades on the Board, and the appointment will beco…

15 April 2026

Medical College of Wisconsin Announces President and CEO

The Medical College of Wisconsin (MCW) announced that Shekar N. Kurpad, MD, PhD, FEL '01, has been unanimously appointed as the institution's seventh president and chief executive officer (CEO), effective July 1, 2026. Dr. Kurpad currently serves as professor of Neurosurgery and senior associate dean, Neuroscience in …

14 April 2026

symplr Appoints Venkat Kavarthapu as CEO

symplr®, a leader in enterprise healthcare operations software backed by Clearlake Capital Group, L.P.and Charlesbank Capital Partners announced the appointment of Venkat Kavarthapu as Chief Executive Officer, effective immediately. He succeeds Chris Colpitts, who has served as interim CEO since November 2025. Mr. Col…

14 April 2026

Boston Aesthetics Appoints Brandon Nye as Chief Executive Officer

Boston Aesthetics announced the appointment of Brandon Nye as Chief Executive Officer, effective immediately. Nye will lead the company's strategic growth initiatives, commercial expansion, and operating execution as Boston Aesthetics enters its next phase of market development in the global medical aesthetics sector.…

Page 6 of 16

slot gacor